16.01.2013 Views

Publications - MPIfG

Publications - MPIfG

Publications - MPIfG

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Fritz W. Scharpf<br />

Was man von einer europäischen Verfassung erwarten und<br />

nicht erwarten sollte. In: Blätter für deutsche und internationale<br />

Politik, Januar 2003, 49–59<br />

Fritz W. Scharpf<br />

Legitimate Diversity: The New Challenge of European Integration.<br />

In: Staats- und Europawissenschaften, Vol. 1, Heft 1,<br />

32–60 (2003)<br />

Fritz W. Scharpf<br />

Regieren im europäischen Mehrebenensystem: Ansätze zu<br />

einer Theorie. In: Leviathan, Vol. 30, No. 1, 65–92 (2002)<br />

Fritz W. Scharpf<br />

The European Social Model: Coping with the Challenges of<br />

Diversity. In: Journal of Common Market Studies, Vol. 40, No.<br />

4, 645–670 (2002)<br />

Fritz W. Scharpf<br />

Globalization and the Welfare State: Constraints, Challenges,<br />

and Vulnerabilities. In: Roland Sigg, Christina Behrendt<br />

(eds.), Social Security in the Global Village. New Brunswick:<br />

Transaction, 2002, 85–116<br />

Fritz W. Scharpf<br />

Democratic Legitimacy under Conditions of Regulatory<br />

Competition: Why Europe Differs from the United States. In:<br />

Kalypso Nicolaidis, Robert Howse (eds.), The Federal Vision:<br />

Legitimacy and Levels of Governance in the United States and<br />

the European Union. New York: Oxford University Press, 2001,<br />

355–374<br />

Fritz W. Scharpf<br />

Notes Toward a Theory of Multilevel Governing in Europe.<br />

In: Scandinavian Political Studies, Vol. 24, No. 1, 1–26 (2001)<br />

Pension Reform Politics in International<br />

Comparison<br />

Martin Schludi<br />

National pension schemes are facing substantial pressure to<br />

adapt to international competition and demographic change,<br />

especially in countries where the public/private pension mix<br />

is dominated by a publicly financed, pay-as-you-go system<br />

(so-called Bismarck systems). This study analyzes the conditions<br />

under which pension systems in such countries can<br />

become more fiscally stable and efficient, especially by<br />

expanding the role of private and fully-funded pension plans.<br />

Thus far, there has been little systematic, comparative empirical<br />

research on the scope and effectiveness of such reform.<br />

This doctoral project aims to close this gap and to examine<br />

the economic, institutional and political factors which have<br />

favored, hampered or even prevented the development of<br />

effective pension policies. It departs from a hypothesis that<br />

the political feasibility of such reforms heavily depends on the<br />

government’s ability to orchestrate a reform consensus either<br />

Project Areas and Research Projects<br />

Martin Schludi Jürgen Feick<br />

with the parliamentary opposition or with the trade unions.<br />

Project duration: January 2000 to December 2002.<br />

Martin Schludi<br />

The Reform of Bismarckian Pension Systems: A Comparison of<br />

Pension Politics in Austria, France, Germany, Italy and Sweden.<br />

Doctoral thesis. Humboldt-Universität Berlin, Faculty of Arts<br />

III. December 2002<br />

Martin Schludi<br />

The Politics of Pensions in European Social Insurance Countries.<br />

<strong>MPIfG</strong> Discussion Paper 01/11. Cologne: Max Planck<br />

Institute for the Study of Societies, 2001, 49 pp.<br />

The Regulation of Pharmaceutical Products<br />

in Europe<br />

Jürgen Feick<br />

In the early sixties the European Commission started discussions<br />

about market entry regulation for pharmaceuticals parallel<br />

to and in interdependence with similar national efforts.<br />

The Commission tried to avoid divergent national policies<br />

which would hinder the establishment of the Single Market.<br />

In a first phase legal harmonization was supposed to, but in<br />

fact did not assure mutual recognition of the Member State<br />

authorities’ regulatory decisions. In a second phase, more<br />

detailed harmonization directives have been introduced<br />

alongside procedural cooperation measures. These further<br />

attempts proved inadequate, too, resulting eventually in the<br />

institutionalization of a European Evaluation Agency and the<br />

introduction of a centralized European procedure – albeit<br />

limited to innovative pharmaceuticals. Today, three distinctive<br />

procedures exist within the EC: the centralized procedure<br />

dominated by European regulators; the decentralized procedure,<br />

which is nationally dominated but potentially subject to<br />

strong EC influence; and purely national market entries. This<br />

project analyzes the transnationalization of pharmaceutical<br />

21

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!